Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study.
complementary medicine
preventive medicine
public health
sexual medicine
virology
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
21 04 2022
21 04 2022
Historique:
entrez:
22
4
2022
pubmed:
23
4
2022
medline:
26
4
2022
Statut:
epublish
Résumé
Identifying factors associated with human papillomavirus (HPV) vaccine uptake is essential for designing successful vaccination programmes. We aimed to examine the association between vaccine hesitancy (VH) and HPV vaccine uptake among male and female youth in Switzerland. With a cross-sectional study, an interview-based questionnaire was used to collect information on sociodemographic factors, vaccination records and to measure the prevalence of VH using the Youth Attitudes about Vaccines scale (YAV-5), a modified version of the Parent Attitudes about Childhood Vaccinations survey instrument. Eligible male and female participants, 15-26 years of age, were recruited through physicians' offices and military enlistment in all three language regions of Switzerland. Of 1001 participants, we included 674 participants with a vaccination record available (415 males and 259 females) in this study. The outcome was uptake for HPV vaccine (having received ≥1 dose of HPV vaccine). Covariates were VH, sex, age and other sociodemographics. 151 (58%) female and 64 (15%) male participants received ≥1 dose of HPV vaccine. 81 (31%) female and 92 (22%) male participants were VH (YAV-5-Score >50). The odds for being unvaccinated were higher for VH women than non-VH women, adjusted OR=4.90 (95% CI 2.53 to 9.50), but similar among VH and non-VH men, OR=1.90 (95% CI 0.84 to 4.31). The odds for being unvaccinated were lower for younger men (born on or after 1 July 2002) than older men (born before 1 July 2002), OR=0.34 (95% CI 0.14 to 0.81), but we found no association between age and vaccine uptake for female youth, OR=0.97 (95% CI 0.48 to 1.97). VH was associated with lower HPV vaccine uptake in female youth but not male youth in our study population in Switzerland. Our findings suggest that issues other than VH contribute to HPV underimmunisation in male youth in Switzerland.
Identifiants
pubmed: 35450894
pii: bmjopen-2021-053754
doi: 10.1136/bmjopen-2021-053754
pmc: PMC9024257
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e053754Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Hum Vaccin Immunother. 2020 Nov 1;16(11):2744-2751
pubmed: 32298210
Am J Mens Health. 2019 Nov-Dec;13(6):1557988319883776
pubmed: 31787066
Worldviews Evid Based Nurs. 2016 Oct;13(5):390-395
pubmed: 27458811
PLoS One. 2018 Apr 11;13(4):e0195801
pubmed: 29641563
Int J Public Health. 2018 Jan;63(1):105-114
pubmed: 29110027
BMJ Open. 2018 May 17;8(5):e021006
pubmed: 29773702
JAMA Pediatr. 2013 Nov;167(11):1065-71
pubmed: 24061681
Vaccine. 2017 Aug 24;35(36):4713-4721
pubmed: 28757059
Vaccine. 2016 Sep 22;34(41):4964-4968
pubmed: 27566902
BMJ Open. 2019 Nov 2;9(11):e032218
pubmed: 31678955
Soc Sci Med. 2018 Jan;196:106-114
pubmed: 29175699
Vaccine. 2019 Dec 10;37(52):7539-7546
pubmed: 31630937
J Adolesc Young Adult Oncol. 2019 Oct;8(5):495-511
pubmed: 31090474
Arch Public Health. 2019 Jun 18;77:29
pubmed: 31236272
Vaccine. 2012 Sep 7;30(41):5928-34
pubmed: 22841973
PLoS One. 2018 Dec 31;13(12):e0197648
pubmed: 30596646
Vaccine. 2020 Aug 27;38(38):6027-6037
pubmed: 32758380
BMJ Open. 2018 Apr 20;8(4):e019206
pubmed: 29678965
BMC Public Health. 2016 Dec 5;16(1):1223
pubmed: 27919239
PLoS Med. 2020 Oct 15;17(10):e1003354
pubmed: 33057373
J Adolesc Health. 2017 Sep;61(3):288-293
pubmed: 28842066
JAMA Pediatr. 2019 Dec 1;173(12):1123-1124
pubmed: 31589246
Prev Med. 2017 Feb;95:26-37
pubmed: 27932052
Clin Pediatr (Phila). 2016 Jun;55(6):537-42
pubmed: 26581360
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccine. 2015 May 11;33(20):2387-94
pubmed: 25843203
J Am Coll Health. 2022 May-Jun;70(4):1079-1093
pubmed: 32672495
Hum Vaccin Immunother. 2021 Dec 2;17(12):5183-5190
pubmed: 34752179
NCHS Data Brief. 2019 Jan;(331):1-8
pubmed: 30707670
Hum Vaccin. 2011 Apr;7(4):419-25
pubmed: 21389777
J Pediatric Infect Dis Soc. 2013 Mar;2(1):40-9
pubmed: 26619441
Swiss Med Wkly. 2008 Nov 29;138(47-48):713-8
pubmed: 19043817
Vaccine. 2017 Dec 19;35(52):7312-7321
pubmed: 29126806
Hum Vaccin Immunother. 2018 Jul 3;14(7):1558-1565
pubmed: 29641945
Vaccine. 2018 May 3;36(19):2545-2558
pubmed: 29625768
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702
pubmed: 31415491
Prev Med. 2020 Feb;131:105968
pubmed: 31881235
Vaccine. 2015 Mar 30;33(14):1748-55
pubmed: 25659278
Am J Mens Health. 2018 Nov;12(6):1966-1975
pubmed: 30334489
Hum Vaccin Immunother. 2021 Aug 3;17(8):2652-2660
pubmed: 33760690